Tech Company Financing Transactions

Vivid Dx Funding Round

Vivid Dx, based in Littlemore, Oxford, secured $15 million from Cedars-Sinai Medical Center, Oxford Science Enterprises and private investors.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Life Sciences

Mailing Address

Magdalen Centre
Littlemore, Oxford, OX4 4GA
UK

Phone

Undisclosed

Website

www.vivid-dx.com

Email Address

Not Recorded

Overview

Vivid Dx was founded to address one of healthcare's most urgent and costly challenges: diagnostic delays that contribute to millions of sepsis-related deaths each year and accelerate the spread of antimicrobial resistance (AMR). Our mission is to disrupt the multibillion-dollar blood culture-based diagnostics market with a next-generation platform that enables faster clinical decisions, improved patient outcomes, and substantial cost savings.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chairman

Timothy Still

        

Chief Executive Officer

Keith O'Neill

        

Chief Operating Officer

Mike Risley

        

Chief Technical Officer

Jeff Liu

        

Browse more venture capital transactions:

Prev: 7/29/2026: Healia venture capital transaction
Next: 7/29/2026: Spur Intelligence venture capital transaction

Share this article

Where The Data Comes From

We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary